title: Predicting response to interleukin-2 therapy among patients with renal cell carcinoma.
authors.affiliation: Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1738, USA.
authors.forename: John T
authors.initials: JT
authors.lastname: Leppert
authors.forename: John S
authors.initials: JS
authors.lastname: Lam
authors.forename: Arie S
authors.initials: AS
authors.lastname: Belldegrun
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000628:therapy*; D045744:Cell Line, Tumor; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D007376:Interleukin-2